372 related articles for article (PubMed ID: 22854654)
1. Extended-field intensity-modulated radiotherapy and concurrent cisplatin-based chemotherapy for postoperative cervical cancer with common iliac or para-aortic lymph node metastases: a retrospective review in a single institution.
Zhang G; Fu C; Zhang Y; Wang J; Qiao N; Yang Q; Cheng Y
Int J Gynecol Cancer; 2012 Sep; 22(7):1220-5. PubMed ID: 22854654
[TBL] [Abstract][Full Text] [Related]
2. Low-dose, prophylactic, extended-field, intensity-modulated radiotherapy plus concurrent weekly cisplatin for patients with stage IB2-IIIB cervical cancer, positive pelvic lymph nodes, and negative para-aortic lymph nodes.
Liang JA; Chen SW; Hung YC; Yeh LS; Chang WC; Lin WC; Chang YY
Int J Gynecol Cancer; 2014 Jun; 24(5):901-7. PubMed ID: 23975081
[TBL] [Abstract][Full Text] [Related]
3. Toxicity and early clinical outcomes in cervical cancer following extended field helical tomotherapy to para-aortic lymph nodes.
Jouglar E; Thomas L; de la Rochefordière A; Noël G; Le Blanc-Onfroy M; Delpon G; Campion L; Mahé MA
Cancer Radiother; 2016 Dec; 20(8):794-800. PubMed ID: 28270323
[TBL] [Abstract][Full Text] [Related]
4. Extended-field intensity-modulated radiation therapy combined with concurrent chemotherapy for cervical cancer with para-aortic lymph nodes metastasis.
Liu X; Wang W; Meng Q; Zhang F; Hu K
Jpn J Clin Oncol; 2019 Mar; 49(3):263-269. PubMed ID: 30668725
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of semiextended field intensity-modulated radiation therapy and concurrent cisplatin in locally advanced cervical cancer patients: An observational study of 10-year experience.
Lee J; Lin JB; Sun FJ; Chen YJ; Chang CL; Jan YT; Wu MH
Medicine (Baltimore); 2017 Mar; 96(10):e6158. PubMed ID: 28272204
[TBL] [Abstract][Full Text] [Related]
6. Extended field radiotherapy with or without chemotherapy in patients with cervical cancer and positive para-aortic lymph nodes: a single institution retrospective review.
Ng BH; Rozita A; Adlinda A; Lee WC; Wan Zamaniah W
Asian Pac J Cancer Prev; 2015; 16(9):3827-33. PubMed ID: 25987044
[TBL] [Abstract][Full Text] [Related]
7. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
[TBL] [Abstract][Full Text] [Related]
8. Outcomes for patients with cervical cancer treated with extended-field intensity-modulated radiation therapy and concurrent cisplatin.
Jensen LG; Hasselle MD; Rose BS; Nath SK; Hasan Y; Scanderbeg DJ; Yashar CM; Mundt AJ; Mell LK
Int J Gynecol Cancer; 2013 Jan; 23(1):119-25. PubMed ID: 23262521
[TBL] [Abstract][Full Text] [Related]
9. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
[TBL] [Abstract][Full Text] [Related]
10. Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer.
Beriwal S; Gan GN; Heron DE; Selvaraj RN; Kim H; Lalonde R; Kelley JL; Edwards RP
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):166-71. PubMed ID: 17321070
[TBL] [Abstract][Full Text] [Related]
11. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
12. Definitive extended field intensity-modulated radiotherapy and concurrent cisplatin chemosensitization in the treatment of IB2-IIIB cervical cancer.
Zhang G; He F; Fu C; Zhang Y; Yang Q; Wang J; Cheng Y
J Gynecol Oncol; 2014 Jan; 25(1):14-21. PubMed ID: 24459576
[TBL] [Abstract][Full Text] [Related]
13. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.
Marnitz S; Martus P; Köhler C; Stromberger C; Asse E; Mallmann P; Schmidberger H; Affonso Júnior RJ; Nunes JS; Sehouli J; Budach V
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):243-53. PubMed ID: 26853333
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes of extended-field radiation therapy and the effect of concurrent chemotherapy on uterine cervical cancer with para-aortic lymph node metastasis.
Yoon HI; Cha J; Keum KC; Lee HY; Nam EJ; Kim SW; Kim S; Kim YT; Kim GE; Kim YB
Radiat Oncol; 2015 Jan; 10():18. PubMed ID: 25582425
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer.
Contreras J; Srivastava A; Chundury A; Schwarz JK; Markovina S; Thaker PH; Massad LS; Mutch DG; Powell MA; Grigsby PW; Lin AJ
Int J Gynecol Cancer; 2020 Aug; 30(8):1157-1161. PubMed ID: 32527770
[TBL] [Abstract][Full Text] [Related]
16. Definitive extended-field intensity-modulated radiotherapy with chemotherapy for cervical cancer with para-aortic nodal metastasis.
Jung J; Park G; Kim YS
Anticancer Res; 2014 Aug; 34(8):4361-6. PubMed ID: 25075072
[TBL] [Abstract][Full Text] [Related]
17. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
Kim JS; Kim JS; Kim SY; Kim Ki; Cho MJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1247-53. PubMed ID: 12654434
[TBL] [Abstract][Full Text] [Related]
18. Extended field chemoradiation for cervical cancer patients with histologically proven para-aortic lymph node metastases after laparaoscopic lymphadenectomy.
Marnitz S; Schram J; Budach V; Sackerer I; Vercellino GF; Sehouli J; Köhler C
Strahlenther Onkol; 2015 May; 191(5):421-8. PubMed ID: 25413986
[TBL] [Abstract][Full Text] [Related]
19. Patterns of failure after use of (18)F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases.
Chung YL; Horng CF; Lee PI; Chen FL
BMC Cancer; 2016 Mar; 16():179. PubMed ID: 26940959
[TBL] [Abstract][Full Text] [Related]
20. Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer.
Folkert MR; Shih KK; Abu-Rustum NR; Jewell E; Kollmeier MA; Makker V; Barakat RR; Alektiar KM
Gynecol Oncol; 2013 Feb; 128(2):288-93. PubMed ID: 23159818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
